In addition, China’s discontinued supply of imported IFN (mostly Interferon alfa-2b recombinant for injection) spurred us to investigate better alternatives to the adjuvant therapy of resected advanced-stage melanoma. The gene discussed is IFNA1; the disease is melanoma.